This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert Jacobson, MD; Gillis W. Long Hansen

Arch Dermatol. 1990;126(12):1627-1630.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Although we have made considerable progress in our understanding and management of leprosy, articles such as that by Gelber et al in this issue of the ARCHIVES¹ serve to remind US physicians that leprosy still exists, and remains a major world health problem. Currently, the World Health Organization estimates that there are 10 to 12 million cases in the world, but only 4 to 5 million are registered. While these figures were relatively stable for years, incidence and prevalence have now started to decline in some areas as a result of the relatively new short-term therapy and improved control measures. On the other hand, a number of reports of leprosy in patients with the acquired immunodeficiency syndrome have recently been published.² The immune deficit associated with the acquired immunodeficiency syndrome has led to an increased incidence of tuberculosis and other mycobacterial diseases in these patients, and it is . . . [Full Text PDF of this Article]

Author Affiliations
Department of Health and Human Services; Disease Center Carville, LA 70721

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?